Artelo Biosciences is leading the industry with research and development of a robust pipeline of novel, endocannabinoid system modulating therapeutics. Our programs have the potential to dramatically improve patient care in major markets where significant unmet needs exist.
Vision and culture
We expect to deliver on the promise of new medicines to treat a wide range of diseases and conditions for patients in need of better outcomes. By doing so, we will create value for patients, physicians, and our investors.
We expect to deliver on the promise of bringing science and validation to the endocannabinoid therapeutic potential, creating value for patients, healthcare providers and our investors. To realize our goals, we will:
- Apply proven pharmaceutical development rigor to our initiatives
- Vigorously protect intellectual property and portfolio value
- Deliver therapies to patients with unmet needs
- Partner with world-class experts who share our drive and passion for success
Our five guiding principles empower our corporate culture:
- Prioritize innovation
- Act with trust & integrity
- Be decisive
- Encourage speed and simplicity
- Foster teamwork
